Ethnic and Gender Differences in HPV Knowledge, Awareness, and Vaccine Acceptability Among White and Hispanic Men and Women
Ethnic and Gender Differences in HPV Knowledge, Awareness, and Vaccine Acceptability Among White and Hispanic Men and Women
复制标题
DOI：
10.1007/s10900-013-9773-y
复制
发表时间：
2014-04-01
影响因子：
5.9
通讯作者：
Gerrard, Meg
中科院分区：
文献类型：
--
作者：
Reimer, Rachel A.;Schommer, Julie A.;Gerrard, Meg
这项研究的目的是在白人和西班牙裔男性和女性中检查与人类乳头瘤病毒(HPV)知识和意识以及HPV疫苗接种相关的因素。检查了HPV知识、信息来源、疫苗意识、疫苗接种状况和对疫苗接种兴趣的差异。2010年5月至2011年12月期间，从中西部一个中等规模城市的当地卫生保健诊所招募了一个社区样本。参与者(N=507)是白人(n=243)和西班牙裔，男性(n=202)和年龄在15-30岁之间的女性。结果表明，白人和女性参与者更有可能听说过HPV，拥有更高水平的HPV知识，被诊断为HPV，并知道女性HPV疫苗。白人和女性参与者也更有可能从他们的医生那里听说过HPV，并且对未来接种HPV疫苗的兴趣要大得多。然而，根据医生的建议，种族对疫苗的兴趣没有影响。研究结果表明，白人和女性对HPV的认识和知识水平更高，虽然西班牙裔参与者比白人参与者从提供者那里得知HPV疫苗的可能性较小，但他们可能同样接受这样的建议。
The purpose of this study was to examine factors associated with human papillomavirus (HPV) knowledge and awareness, and HPV vaccination among White and Hispanic males and females. Differences in HPV knowledge, sources of information, vaccine awareness, vaccination status, and interest in vaccination were examined. A community sample was recruited from local health care clinics in a medium sized Midwestern city between May 2010 and December 2011. Participants (N = 507) were White (n = 243) and Hispanic, males (n = 202) and females between the ages of 15-30. Results indicate that White and female participants were significantly more likely to have heard of HPV, have higher levels of HPV knowledge, have been diagnosed with HPV, and be aware of the HPV vaccine for women. White and female participants were also more likely to have heard of HPV from their physician and were significantly more interested in receiving the HPV vaccine in the future. There was no effect of ethnicity on interest in the vaccine per a doctor's recommendation, however. Findings suggest that Whites and females have greater levels of HPV awareness and knowledge and that, while Hispanic participants are less likely than White participants to be told about the HPV vaccine from their provider, they may be equally receptive to such a recommendation.